Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1985-2-19
|
| pubmed:abstractText |
Post-phlebitic syndromes, the result of late diagnosis at the acute stage and/or inappropriate treatment, are disorders which are still very widespread, chronic, and more or less incapacitating. For fifty years, there has been no new really and lastingly active medication to improve the local condition and check the aggravation. However, heparin is still the least ineffectual form of medication. Applied in series of treatment of 10/15 days, preferably by route IV, it alone is able to produce consistently fair results. Taken on average with the application precautions, the risks with standard doses are practically nil.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0031-8280
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
37
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
479-81
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
[The value of heparin in postphlebitic syndromes].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|